Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
Lipid Metabolism, Inborn Errors
MeSH Descriptor Data 2024
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Lipid Metabolism, Inborn Errors
Tree Number(s)
C16.320.565.398
C18.452.584.563
C18.452.648.398
Unique ID
D008052
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D008052
Annotation
coordinate with specific lipid
/metab
Scope Note
Errors in the metabolism of
LIPIDS
resulting from inborn genetic
MUTATIONS
that are heritable.
Entry Version
LIPID METAB INBORN ERR
Entry Term(s)
Lipid Metabolism, Inborn Error
NLM Classification #
QU 265.5.L5
Public MeSH Note
65
History Note
65
Date Established
1965/01/01
Date of Entry
1999/01/01
Revision Date
2021/07/01
Allowable Qualifiers
blood (BL)
cerebrospinal fluid (CF)
chemically induced (CI)
classification (CL)
complications (CO)
diagnosis (DI)
diagnostic imaging (DG)
diet therapy (DH)
drug therapy (DT)
economics (EC)
embryology (EM)
enzymology (EN)
epidemiology (EP)
ethnology (EH)
etiology (ET)
genetics (GE)
history (HI)
immunology (IM)
metabolism (ME)
microbiology (MI)
mortality (MO)
nursing (NU)
parasitology (PS)
pathology (PA)
physiopathology (PP)
prevention & control (PC)
psychology (PX)
radiotherapy (RT)
rehabilitation (RH)
surgery (SU)
therapy (TH)
urine (UR)
veterinary (VE)
virology (VI)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Genetic Diseases, Inborn [C16.320]
Metabolism, Inborn Errors [C16.320.565]
Amino Acid Metabolism, Inborn Errors [C16.320.565.100]
Amino Acid Transport Disorders, Inborn [C16.320.565.151]
Amyloidosis, Familial [C16.320.565.176]
Brain Diseases, Metabolic, Inborn [C16.320.565.189]
Carbohydrate Metabolism, Inborn Errors [C16.320.565.202]
Cytochrome-c Oxidase Deficiency [C16.320.565.240]
Hyperbilirubinemia, Hereditary [C16.320.565.300]
Lipid Metabolism, Inborn Errors [C16.320.565.398]
Barth Syndrome [C16.320.565.398.224]
Hyperlipidemia, Familial Combined [C16.320.565.398.450]
Hyperlipoproteinemia Type I [C16.320.565.398.465]
Hyperlipoproteinemia Type II [C16.320.565.398.481]
Hyperlipoproteinemia Type III [C16.320.565.398.483]
Hyperlipoproteinemia Type IV [C16.320.565.398.487]
Hyperlipoproteinemia Type V [C16.320.565.398.493]
Hypolipoproteinemias [C16.320.565.398.500]
Lipidoses [C16.320.565.398.641]
Lipodystrophy, Congenital Generalized [C16.320.565.398.745]
Smith-Lemli-Opitz Syndrome [C16.320.565.398.850]
Xanthomatosis, Cerebrotendinous [C16.320.565.398.925]
Lysosomal Storage Diseases [C16.320.565.595]
Metal Metabolism, Inborn Errors [C16.320.565.618]
Peroxisomal Disorders [C16.320.565.663]
Progeria [C16.320.565.753]
Purine-Pyrimidine Metabolism, Inborn Errors [C16.320.565.798]
Renal Tubular Transport, Inborn Errors [C16.320.565.893]
Steroid Metabolism, Inborn Errors [C16.320.565.925]
Nutritional and Metabolic Diseases [C18]
Metabolic Diseases [C18.452]
Lipid Metabolism Disorders [C18.452.584]
Dyslipidemias [C18.452.584.500]
Lipid Metabolism, Inborn Errors [C18.452.584.563]
Barth Syndrome [C18.452.584.563.224]
Hyperlipidemia, Familial Combined [C18.452.584.563.450]
Hyperlipoproteinemia Type I [C18.452.584.563.465]
Hyperlipoproteinemia Type II [C18.452.584.563.481]
Hyperlipoproteinemia Type III [C18.452.584.563.483]
Hyperlipoproteinemia Type IV [C18.452.584.563.487]
Hyperlipoproteinemia Type V [C18.452.584.563.493]
Hypobetalipoproteinemia, Familial, Apolipoprotein B [C18.452.584.563.497]
Hypolipoproteinemias [C18.452.584.563.500]
Lipidoses [C18.452.584.563.641]
Lipodystrophy, Congenital Generalized [C18.452.584.563.745]
Lipodystrophy, Familial Partial [C18.452.584.563.798]
Shwachman-Diamond Syndrome [C18.452.584.563.824]
Smith-Lemli-Opitz Syndrome [C18.452.584.563.850]
Xanthomatosis, Cerebrotendinous [C18.452.584.563.925]
Lipodystrophy [C18.452.584.625]
Lipomatosis [C18.452.584.718]
Xanthomatosis [C18.452.584.750]
Nutritional and Metabolic Diseases [C18]
Metabolic Diseases [C18.452]
Metabolism, Inborn Errors [C18.452.648]
Amino Acid Metabolism, Inborn Errors [C18.452.648.100]
Amino Acid Transport Disorders, Inborn [C18.452.648.151]
Amyloidosis, Familial [C18.452.648.176]
Brain Diseases, Metabolic, Inborn [C18.452.648.189]
Carbohydrate Metabolism, Inborn Errors [C18.452.648.202]
Hyperbilirubinemia, Hereditary [C18.452.648.300]
Lipid Metabolism, Inborn Errors [C18.452.648.398]
Barth Syndrome [C18.452.648.398.224]
Hyperlipidemia, Familial Combined [C18.452.648.398.450]
Hyperlipoproteinemia Type I [C18.452.648.398.465]
Hyperlipoproteinemia Type II [C18.452.648.398.481]
Hyperlipoproteinemia Type III [C18.452.648.398.483]
Hyperlipoproteinemia Type IV [C18.452.648.398.487]
Hyperlipoproteinemia Type V [C18.452.648.398.493]
Hypolipoproteinemias [C18.452.648.398.500]
Lipidoses [C18.452.648.398.641]
Lipodystrophy, Congenital Generalized [C18.452.648.398.745]
Smith-Lemli-Opitz Syndrome [C18.452.648.398.850]
Xanthomatosis, Cerebrotendinous [C18.452.648.398.925]
Lysosomal Storage Diseases [C18.452.648.595]
Metal Metabolism, Inborn Errors [C18.452.648.618]
Peroxisomal Disorders [C18.452.648.663]
Progeria [C18.452.648.753]
Purine-Pyrimidine Metabolism, Inborn Errors [C18.452.648.798]
Renal Tubular Transport, Inborn Errors [C18.452.648.893]
Steroid Metabolism, Inborn Errors [C18.452.648.925]
Expand All
Collapse All
Lipid Metabolism, Inborn Errors
Preferred
Concept UI
M0012549
Scope Note
Errors in the metabolism of
LIPIDS
resulting from inborn genetic
MUTATIONS
that are heritable.
Terms
Lipid Metabolism, Inborn Errors
Preferred Term
Term UI
T023993
Date
01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1965)
Lipid Metabolism, Inborn Error
Term UI
T023992
Date
05/24/1990
LexicalTag
NON
ThesaurusID
NLM (1991)
page delivered in 0.173s